Page 59 - AN-2-1
P. 59

Advanced Neurology                                     Restless legs syndrome in end-stage renal disease patients



            3. Results                                         scores, except the subscales “physical component score,”
                                                               “social functioning,” and “general health” (P < 0.005). The
            The demographic data and clinical analysis results of the   RLS-negative patients had higher scores on the subscales
            286 patients on hemodialysis are shown in Table 1. Of the   physical functioning (P = 0.019), role limitations due
            total, 41 patients (14.34%) were diagnosed with RLS with   to physical health (P = 0.018), pain (P = 0.011), mental
            a male/female ratio of 16/25. Chronic glomerulonephrites   component score (P = 0.009), energy/vitality (P = 0.009),
            is the primary disease in 155 patients (54.2%). The RLS   vitality (P = 0.005), emotion (P = 0.027), and mental health
            severity score was 14.39 ± 9.75; there were 8 mild cases   (P = 0.010) than those RLS-positive patients (Table 3). Sleep
            (19.51%), 25 moderate cases (60.98%), 6 severe cases   disorders were considered more common in RLS-positive
            (14.63%), and 2 very severe cases (4.88%). There was no   patients. These disorders included total PSQI global score,
            significant association between RLS and gender, mean age,   subjective sleep quality, sleep latency, duration of sleep,
            body mass index (BMI), smoking, drinking, mean age at   habitual sleep efficiency, and sleep disturbances (P < 0.05).
            the initiation of hemodialysis, hemodialysis duration,   However, there was no difference in the use of sleep
            primary disease, and drug usage (P > 0.05).        medication and daytime dysfunction (P > 0.05), as shown

              The means of laboratory data, including hemoglobin,   in Table 4 and Table 5.
            serum creatinine, uric  acid,  plasma  albumin,  calcium,
            phosphorus, magnesium, i-PTH, ferritin, and transferrin   4. Discussion
            saturation, are shown in Table 2. No significant difference   Even though investigations into the etiopathogenesis of
            between the two groups (RLS-positive and RLS-negative   RLS have been conducted for many years, RLS is regarded
            patients) regarding all the laboratory data, including   as a complex condition in which genetic background,
            pre/post-dialysis mean systolic/diastolic BP, BUN,   environmental variables, and gene-environment interactions
            creatinine, albumin, hemoglobin, ferritin, iron saturation,   are  more  likely to cause  illness.  Thousands  of  genetic
            iron, TIBC, calcium, phosphorus, Ca×P product, i-PTH,   studies have shown the hereditary variability of the illness
            CRP, and β2-MG, was observed. There was a significant   and RLS is now considered a complicated congenital
            relationship between RLS severity and all SF-36 subscale   disorder. Large-scale genome-wide association study

            Table 1. Clinical characteristics of patients on hemodialysis with and without RLS
                                                              RLS                Non‑RLS               P‑value
            Sex (female/male)                                25/16                132/113              0.3979
            Mean age (years)                               56.37±14.35           54.64±15.13           0.4954
            BMI (mean±SD)                                   22.58±3.41           23.61±3.62             0.090
            Smoking                                        22 (53.66%)          141 (57.55%)            0.217
            Drinking                                       23 (56.10%)          145 (59.18%)           0.1380
            Mean age at the initiation of hemodialysis (years)  48.26±11.26      51.26±13.17           0.1698
            Hemodialysis duration (years)
             ≤5                                            25 (60.98%)          153 (62.45%)           0.8571
             5–10                                          10 (24.39%)           66 (26.94%)           0.7324
             ≥10                                            6 (14.63%)           26 (10.61%)           0.4496
            Primary disease
             Chronic glomerulonephritis                    18 (43.90%)          137 (55.92%)           0.1529
             Diabetic nephropathy                           7 (17.07%)           29 (11.84%)           0.3459
             Hypertensive nephropathy                       9 (21.95%)           35 (14.29%)           0.2080
             Others                                         7 (17.07%)           44 (17.96%)           0.8909
            Drug
             Vitamins                                      17 (41.46%)           71 (28.98%)           0.1089
             Anti-osteoporosis                             27 (65.85%)          167 (68.16%)           0.7695
             Erythropoietin and iron supplements           31 (75.61%)          203 (82.86%)           0.2655
            BMI: Body mass index; RLS: Restless legs syndrome. Categorical variables are expressed as percentage while continuous variables are expressed as
            mean±standard deviation. *P<0.05


            Volume 2 Issue 1 (2023)                         4                          https://doi.org/10.36922/an.210
   54   55   56   57   58   59   60   61   62   63   64